Back to GetFilings.com




 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended November 28, 2003

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File No. 001-12392

 


 

NDCHealth Corporation

(Exact name of registrant as specified in charter)

 


 

DELAWARE   58-0977458

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

NDC Plaza, Atlanta, Georgia   30329-2010
Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code 404-728-2000

 

None

(Former name, former address and former fiscal year, if

changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  x    No  ¨.

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨.

 

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

 

Common Stock, Par Value $.125 – 35,703,918 shares

outstanding as of January 5, 2004

 



CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

NDCHealth Corporation and Subsidiaries

 

(In thousands, except per share data)


     Three Months Ended

 
     November 28,
2003


    November 29,
2002


 

Revenues

   $ 115,234     $ 105,286  

Operating expenses:

                

Cost of service

     57,182       51,950  

Sales, general and administrative

     24,822       22,061  

Depreciation and amortization

     9,444       7,501  

Restructuring, impairment and other charges

     2,500       —    
    


 


       93,948       81,512  
    


 


Operating income

     21,286       23,774  

Other income (expense):

                

Interest and other income

     189       467  

Interest and other expense

     (7,603 )     (3,676 )

Minority interest in losses

     471       653  

Early extinguishment of debt charges

     —         (921 )
    


 


       (6,943 )     (3,477 )
    


 


Income before income taxes and equity in losses of affiliated companies

     14,343       20,297  

Provision for income taxes

     5,369       7,307  

Income before equity in losses of affiliated companies

     8,974       12,990  

Equity in losses of affiliated companies

     (240 )     (313 )
    


 


Net income

   $ 8,734     $ 12,677  
    


 


Basic earnings per share:

   $ 0.25     $ 0.37  
    


 


Diluted earnings per share:

   $ 0.25     $ 0.36  
    


 


 

See Notes to Condensed Consolidated Financial Statements.

 

2


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

NDCHealth Corporation and Subsidiaries

 

(In thousands, except per share data)


     Six Months Ended

 
     November 28,
2003


    November 29,
2002


 

Revenues

   $ 224,125     $ 205,368  

Operating expenses:

                

Cost of service

     112,334       103,751  

Sales, general and administrative

     48,008       42,214  

Depreciation and amortization

     18,758       15,110  

Restructuring, impairment and other charges

     3,999       —    
    


 


       183,099       161,075  
    


 


Operating income

     41,026       44,293  

Other income (expense):

                

Interest and other income

     324       745  

Interest and other expense

     (15,316 )     (6,916 )

Minority interest in losses

     623       1,031  

Early extinguishment of debt charges

     —         (921 )
    


 


       (14,369 )     (6,061 )
    


 


Income before income taxes and equity in losses of affiliated companies

     26,657       38,232  

Provision for income taxes

     9,986       13,765  

Income before equity in losses of affiliated companies

     16,671       24,467  

Equity in losses of affiliated companies

     (583 )     (625 )
    


 


Net income

   $ 16,088     $ 23,842  
    


 


Basic earnings per share:

   $ 0.46     $ 0.69  
    


 


Diluted earnings per share:

   $ 0.45     $ 0.68  
    


 


 

See Notes to Condensed Consolidated Financial Statements.

 

3


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

NDCHealth Corporation and Subsidiaries

 

(In thousands)


     Six Months Ended

 
     November 28,
2003


    November 29,
2002


 

Cash flows from operating activities:

                

Net income

   $ 16,088     $ 23,842  

Adjustments to reconcile net income to cash provided by operating activities:

                

Equity in losses of affiliated companies

     583       625  

Non-cash portion of restructuring, impairment and other charges

     1,049       —    

Non-cash early extinguishment of debt charges

     —         805  

Depreciation and amortization

     18,758       15,110  

Deferred income taxes

     9,300       5,342  

Provision for bad debts

     1,791       1,544  

Other, net

     1,597       2,300  

Changes in assets and liabilities which provided (used) cash, net of the effects of acquisitions:

                

Accounts receivable, net

     (3,540 )     (4,029 )

Prepaid expenses and other assets

     (245 )     370  

Accounts payable and accrued liabilities

     7,212       (4,275 )

Accrued interest on long-term debt

     (22 )     862  

Deferred revenue

     1,449       (3,922 )

Income taxes

     560       2,059  
    


 


Net cash provided by operating activities

     54,580       40,633  
    


 


Cash flows from investing activities:

                

Capital expenditures

     (23,721 )     (20,804 )

Proceeds from the sale of equipment

     2,148       —    

Investing activities and other non-current assets

     (7,067 )     (10,244 )
    


 


Net cash used in investing activities

     (28,640 )     (31,048 )
    


 


Cash flows from financing activities:

                

Net repayments under lines of credit

     —         (91,000 )

Net principal payments under capital lease arrangements and other long-term debt

     (2,030 )     (1,625 )

Net cash from refinancing activities

     (395 )     165,945  

Net proceeds from stock activities

     2,645       1,227  

Dividends paid

     (2,820 )     (2,778 )
    


 


Net cash (used in) provided by financing activities

     (2,600 )     71,769  
    


 


Cash flows from discontinued operations:

                

Cash provided by tax benefits of discontinued operations

     —         6,106  

Cash used in discontinued operations

     (859 )     (3,519 )
    


 


Net cash (used in) provided by discontinued operations

     (859 )     2,587  
    


 


Increase in cash and cash equivalents

     22,481       83,941  

Cash and cash equivalents, beginning of period

     16,103       13,447  
    


 


Cash and cash equivalents, end of period

   $ 38,584     $ 97,388  
    


 


 

See Notes to Condensed Consolidated Financial Statements.

 

4


CONDENSED CONSOLIDATED BALANCE SHEETS

NDCHealth Corporation and Subsidiaries

 

(In thousands, except share data)


     November 28,
2003


    May 30,
2003


 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 38,584     $ 16,103  

Accounts receivable

     80,761       78,988  

Allowance for doubtful accounts

     (7,730 )     (6,785 )
    


 


Accounts receivable, net

     73,031       72,203  
    


 


Income tax receivable

     639       1,199  

Deferred income taxes

     15,377       21,663  

Prepaid expenses and other current assets

     33,888       34,304  
    


 


Total current assets

     161,519       145,472  
    


 


Property and equipment, net

     124,493       116,678  

Intangible assets, net

     475,941       479,234  

Deferred income taxes

     2,312       5,018  

Debt issuance cost

     12,269       12,756  

Investments

     17,345       15,662  

Other

     13,757       12,432  
    


 


Total Assets

   $ 807,636     $ 787,252  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Current portion of long-term debt

   $ 6,590     $ 6,558  

Current portion of obligations under capital leases

     921       1,028  

Accounts payable and accrued liabilities

     63,473       61,211  

Accrued interest

     13,259       13,281  

Deferred revenue

     37,042       38,137  
    


 


Total current liabilities

     121,285       120,215